Brown, Lisle/Cummings, Inc. Pfizer Inc Transaction History
Brown, Lisle/Cummings, Inc.
- $376 Billion
- Q2 2025
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 69,606 shares of PFE stock, worth $1.69 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
69,606
Previous 62,505
11.36%
Holding current value
$1.69 Million
Previous $1.58 Billion
6.53%
% of portfolio
0.45%
Previous 0.46%
Shares
15 transactions
Others Institutions Holding PFE
# of Institutions
3,356Shares Held
3.6BCall Options Held
104MPut Options Held
130M-
Vanguard Group Inc Valley Forge, PA523MShares$12.7 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.3 Billion0.27% of portfolio
-
State Street Corp Boston, MA297MShares$7.22 Billion0.32% of portfolio
-
Geode Capital Management, LLC Boston, MA126MShares$3.05 Billion0.26% of portfolio
-
Wellington Management Group LLP Boston, MA103MShares$2.52 Billion0.52% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $136B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...